This document provides an overview of recovery-enhancing medications for addiction treatment. It discusses how addiction is a brain disease and the importance of understanding the biology. It explains how medications can enhance recovery by targeting neurotransmitters like dopamine and glutamate that are impacted by drug use. The document also discusses how longer treatment lengths are associated with better outcomes and how medications can impact program retention and recovery.
The video for this presentation is available on our Youtube channel: https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
We examine medication assisted therapies for smoking, opiate addiction and alcohol dependence. We also explore the research supporting MAT and approaches that can be taken with clients who abuse drugs for which no MAT is available.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
How do people get addicted? What is Suboxone? Why do people use opiates? Why is it so easy to overdose on opiates?
The video for this presentation is available on our Youtube channel: https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
We examine medication assisted therapies for smoking, opiate addiction and alcohol dependence. We also explore the research supporting MAT and approaches that can be taken with clients who abuse drugs for which no MAT is available.
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
How do people get addicted? What is Suboxone? Why do people use opiates? Why is it so easy to overdose on opiates?
Amphetamine is a stimulant that is primarily used to treat narcolepsy and attention-deficit hyperactivity disorder. It is also used recreationally as a club drug and as a performance enhancer.
DRUG ABUSE & ADDICTION , IDIOSYNCRASY AND TACHYPHYLAXISsarthak845950
This ppt gives us a clear picture of drug addiction and abuse, illegal drugs, tachyphylaxis, idiosyncrasy, and spare receptors. It also tells us about the most common abusable drugs, the effect of drugs on the brain, ethanol abuse, warning signs of addiction, the effect of drugs on body organs, etc.
Unfrying Your Brain- Tonmoy Sharma, CEO of Sovereign HealthDr. Tonmoy Sharma
Tonmoy Sharma, CEO of Sovereign Health Group, reveals how we must view addiction, and how we can reverse serious cognitive deficits that often go undetected in addiction treatment. Sharma also reviews the need for measurement-based care, and outlines in great detail, how the addiction-treatment industry can evolve to better meet the needs of our patients.
Introduction to the BioPsychoSocial approach to Addictionkavroom
In this 45 minute introductory lecture you will learn about the biopsychosocial approach to addiction
At the end of this session you should:
Have an understanding of the neurological systems that underpin addiction.
Appreciate that the ways addiction is explained has a direct influence upon treatment.
Be aware that there is no unified theory of addition, but that an integrated approach can help explain onset and maintenance of addictive behavior.
Amphetamine is a stimulant that is primarily used to treat narcolepsy and attention-deficit hyperactivity disorder. It is also used recreationally as a club drug and as a performance enhancer.
DRUG ABUSE & ADDICTION , IDIOSYNCRASY AND TACHYPHYLAXISsarthak845950
This ppt gives us a clear picture of drug addiction and abuse, illegal drugs, tachyphylaxis, idiosyncrasy, and spare receptors. It also tells us about the most common abusable drugs, the effect of drugs on the brain, ethanol abuse, warning signs of addiction, the effect of drugs on body organs, etc.
Unfrying Your Brain- Tonmoy Sharma, CEO of Sovereign HealthDr. Tonmoy Sharma
Tonmoy Sharma, CEO of Sovereign Health Group, reveals how we must view addiction, and how we can reverse serious cognitive deficits that often go undetected in addiction treatment. Sharma also reviews the need for measurement-based care, and outlines in great detail, how the addiction-treatment industry can evolve to better meet the needs of our patients.
Introduction to the BioPsychoSocial approach to Addictionkavroom
In this 45 minute introductory lecture you will learn about the biopsychosocial approach to addiction
At the end of this session you should:
Have an understanding of the neurological systems that underpin addiction.
Appreciate that the ways addiction is explained has a direct influence upon treatment.
Be aware that there is no unified theory of addition, but that an integrated approach can help explain onset and maintenance of addictive behavior.
Relapse – in a broader sense, is the return of signs and symptoms of a disease after a remission.
In the case of some psychiatric disorders, relapse is the worsening of symptoms or the re-occurrence of unhealthy behaviors, such as avoidance or substance use, after a period of improvement.
Relapse Prevention – A set of skills designed to reduce the likelihood that symptoms of the illness in question will worsen or that a person will return to an unhealthy behavior, such as substance use.
Skills include, for example, identifying early warning signs that symptoms may be worsening, recognizing high risk situations for relapse, and understanding how everyday, seemingly mundane decisions may put you on the road to relapse (for example, skipping lunch one day may make you more vulnerable to get in a bad mood).
Relapse can be prevented through the use of specific coping strategies, such as identifying early warning signs.
Early Intervention is simply bridging the gap between prevention and treatment. Early intervention is essential to reducing drug use and its costs to society
2
Running head: Schizophrenia
Schizophrenia
Classes of drugs used to treat schizophrenia
The most significant common medication used in the treatment of schizophrenia is antipsychotic medication. There are two types of drugs that are typical and atypical, both work to reduce the positive or negative effects of schizophrenia. Antipsychotic drugs are used to treat mental, emotional and psychosis conditions. Psychosis refers to the state in which an individual loses touch with reality; the individual starts having hallucinations or delusions.
To alleviate the problem antipsychotic drugs are used to regulate the levels of neurotransmitters in the brain.
Explain their action at the neurotransmitter system.
Schizophrenia is linked to changes in the activities of the neurotransmitter in some specific parts of the brain. Antipsychotic medication affects this neurotransmitter affecting their activity too. The medication acts by interfering with the chemical messengers and controlling or lessening the symptoms of the disorder like mood swings, hallucinations, and delusions. There are mainly two types of antipsychotic drugs that is typical and atypical antipsychotic drugs.
They work by altering dopamine and serotonin receptors. Typical antipsychotics or first generation psychotics were manufactured first in the 1950s. Its function is to block dopamine receptor known as a D2 receptor. Atypical antipsychotics or the second generation antipsychotics were introduced in the 1990s. Just like typical antipsychotic, they block D2 receptors as well as a serotonin receptor known as a 5-HT2A receptor.
Analyze and describe the agonist-antagonist activity of the drugs and the receptor types and subtypes involved in the disorder.
Partial agonists have a lower rate of activity than full agonists at the receptors. This allows them to function as either a functional agonist or functional antagonist depending on the levels of the neurotransmitter (full agonist). If a neurotransmitter is not present partial agonist display a functional antagonist activity. This is as a result of receptor binding reducing any response with the neurotransmitter.
Partial agonist in dopamine D2 receptors is an alternative option when treating schizophrenia. It acts as a functional antagonist mesolimbic dopamine pathway, and the excessive dopamine activity causes positive symptoms. However, reduced dopamine activity in the mesocortical pathway causes cognitive impairment and negative symptoms.
Elaborate on the receptor agonist-antagonist actions of the drugs and describe the most common side effects seen with these drugs.
Inhibition of dopamine function is the most common feature of antipsychotic drugs. D4 receptor activation in moderate levels helps antipsychotic agents protect the brain from negative and cognitive symptoms of schizophrenia. D2 and D3 receptors help improve positive symptoms of schizophrenia but are not successful in countering negative and cognitiv.
Jetlax's CNS Pharmacology Cheat Sheet for the Philippines v5.0 - see bit.ly_C...JorGarcia2
Pharmacology is an interdisciplinary field that explores many aspects of drug discovery, development and preclinical drug safety. It integrates knowledge from multiple scientific disciplines including chemistry, biochemistry, molecular biology and physiology, providing a significant positive impact on human health.
Pharmacology is the study of the actions of drugs, incorporating knowledge from other sciences. Drugs are classified based on their action or effect on the body or by their chemical characteristics. Nurses must be familiar with both generic and trade names of drugs.
3. OBJECTIVES
! Addiction is a BIO-PSYCH-SOCIAL DISEASE
! To understand the medications, we must pay close
attention to the BIOLOGY
! Medication-Assisted Therapy (Maintenance) vs.
Recovery-Enhancing Medications: Is there a
difference?
! Research and Practice…
SperanzaHealth Clinical Partners
4. What’s all the fuss about
Neuroscience?
! Neuroscience – definition from dictionary.com - the field of
study encompassing the various scientific disciplines dealing
with the structure, development, function, chemistry,
pharmacology, and pathology of the nervous system that
effect the brain.
! Every thought, sensation, emotion, physical movement is
accounted for in terms of brain structures and chemistry.
! In other words… nothing happens in human behavior
except by the mechanisms of the brain.
SperanzaHealth Clinical Partners
5. Is it really a Disease?
! Disease of the brain.
! >33% of Public believes it is simply willpower…HOW
ABOUT CLINICIANS?
! Compared to:
! Type 2 Diabetes, Chronic hypertensive disease, Asthma,
Obesity
! No one treatment episode will resolve illness…hence 12
Steps, Other social supports
! Course of dependency is multiple episodes of treatment,
recovery activities, relapse periods.
SperanzaHealth Clinical Partners
6. Does this matter to what you do?
THERAPY…
SperanzaHealth Clinical Partners
7. Application
“The longer you’re in treatment…”
! Research has shown unequivocally that good outcomes
are contingent on adequate treatment length.
! Generally, for residential or outpatient treatment,
participation for less than 90 days is of limited
effectiveness, and treatment lasting significantly longer
is recommended for maintaining positive outcomes.
SperanzaHealth Clinical Partners
8. Therefore…
! Understanding how the
brain functions during
and after drug use,
encourages practitioners
to correlate appropriate
strategies to the stage of
recovery and
consequently impact on
program retention.
SperanzaHealth Clinical Partners
13. Dopamine
! D2 receptor changes associated with addiction in
people and animals
! Drugs of Abuse cause 5x to 10x increase…
! Chronic exposure to stimulants, opioids or alcohol
leads to decreased dopamine activity
! Decreased sensitivity to everyday rewards
! How does this affect psychotherapy?
Speranza Training Associates
14. The importance of Glutamate
! Memory Formation
! New pharmacological + psychological therapy?
! Glutamate + Dopamine Directly influence the
formation of new memories…
! How does this affect the addict?
30. Like What You've Viewed?
Contact SperanzaHealth Clinical Partners and Ask For About Our Clinical Trainings!
Many completely free trainings throughout the year
Multiple trainers of differing backgrounds
We will come to you, or better yet, use SperanzaHealth Trainers as a marketing tool... call us
today for a completely free needs assessment or to just schedule a training!
724-651-6669 - Christopher Cook
412-447-4677 - Clinicians
SperanzaHealth Clinical Partners is a specialist behavioral health firm. We are a group of
independent, private contractors specializing in:
1. Sub-Contracted Assessment and Referral
2. NEW Sub-contracted Utilization Review RN's
3. Clinical and Corporate Training
4. Business Consultants specializing in MentalHealth and Substance Abuse Tretment Agencies
